EPA's Formaldehyde U-Turn Sparks Battle Over Science and Safety

The Trump administration's decision to weaken exposure limits for the cancer-linked chemical has reignited a decades-long fight between industry and public health advocates over what counts as sound science.
Jan. 20, 2026
7 min read

Key Highlights

  • EPA's IRIS program and its scientific evaluations face criticism from industry groups and political actors, leading to shifts in risk assessment approaches and regulatory policies.
  • Recent policy changes include EPA's move to base exposure limits on sensory irritation, which some experts argue ignores formaldehyde's cancer risks at any exposure level.
  • Industry groups like the American Chemistry Council advocate for science-based, risk-driven regulations to support U.S. manufacturing and innovation, opposing stricter limits that could impact supply chains.

About the Author

Jonathan Katz

Executive Editor

Jonathan Katz, executive editor, brings nearly two decades of experience as a B2B journalist to Chemical Processing magazine. He has expertise on a wide range of industrial topics. Jon previously served as the managing editor for IndustryWeek magazine and, most recently, as a freelance writer specializing in content marketing for the manufacturing sector.

His knowledge areas include industrial safety, environmental compliance/sustainability, lean manufacturing/continuous improvement, Industry 4.0/automation and many other topics of interest to the Chemical Processing audience.

When he’s not working, Jon enjoys fishing, hiking and music, including a small but growing vinyl collection.

Jon resides in the Cleveland, Ohio, area.

Sign up for our eNewsletters
Get the latest news and updates